ERRFI1 and lung cancer: Additionally, Kang et al. 12 claimed that MIG-6 overexpression accelerates cell proliferation, invasion, and epithelial-mesenchymal transition (EMT) in EGFR-directed tyrosine kinase inhibitor (TKI)-resistant lung cancer cells compared with EGFR-TKI sensitive cells.